top of page
< Back

WHERE DOES THE MONEY GO?

IDENTIFYING TARGETS ON MYELOID CELLS TO DESIGN PERSONALISED COMBINATION IMMUNOTHERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER

2021 - 2023

INSTITUTIONS:

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

 

CHIEF RESEARCHER:

Prof. Robin Anderson

Targeting pro-tumour immune cells to improve response to immunotherapy for triple-negative breast cancer patients.

Immunotherapy has shown remarkable success in some types of cancer, especially melanoma. While a modest proportion of patients with triple-negative breast cancer (TNBC) respond well to a form of immunotherapy, called anti-PD-L1 therapy, the majority do not respond - probably because they have too few or inactive lymphocytes (cancer cell-killing immune cells) in the tumour. We have evidence that neutrophil-like cells that normally fight bacterial infections can turn into another type of cell (G-MDSC) in a cancer patient, which in turn helps the cancer grow and spread. By targeting these G-MDSC, we hope to harness the benefits of immunotherapy for many more patients with TNBC. To achieve this goal, we will test three new therapies for their ability to inhibit the G-MDSC population without affecting the actual neutrophils needed to fight infection. The outcome will be a combination therapy targeting G-MDSC cells and PD-L1 that will increase the reach and response to immunotherapy in TNBC patients.

IDENTIFYING TARGETS ON MYELOID CELLS TO DESIGN PERSONALISED COMBINATION IMMUNOTHERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER

FLANKS FOR JOINING!

-  JOIN OUR MAILING LIST - 

Love Your Sister is Australia's hardest-working cancer vanquishing charity, and since its inception in 2012 has raised $20M for medical research.

 

Founded by Gold Logie-winning actor and Victorian Australian of the Year 2018, Samuel Johnson OAM, Love Your Sister is a million-strong village of everyday Aussies committed to vanquishing cancer with hard science and the best new technologies. Love Your Sister supports precision treatment for ALL cancer patients, whatever the cancer, regardless of location, age, income, or status. We strive for the right treatment for every cancer patient, first time, every time.

Love Your Sister pr
oudly passes 100% of all donations received to research.  No skimming. No admin. No BS!

LoveYourSister Corp_2017_Simple2_white.p
acnc-logo-300x300.png

CONTACT US     FAQs 

LOVE YOUR SISTER ABN: 92 770 192 934

© 2024 by LOVE YOUR SISTER

bottom of page